Zobrazeno 1 - 10
of 18
pro vyhledávání: '"WEIJIA DOU"'
Autor:
Yijun Li, Zhihua Guo, Wenqing Tian, Xiuchao Wang, Weijia Dou, Yanfeng Chen, Shen Huang, Shengdong Ni, Hui Wang, Chaoxian Wang, Xufeng Liu, Xia Zhu, Shengjun Wu
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Previous studies have investigated the relationships between psychache or meaning in life and suicidal ideation based on sum score of corresponding scale. However, this practice has hampered the fine-grained understanding of their
Externí odkaz:
https://doaj.org/article/40395cc0aaa4428c94fe29fc1bf186bb
Autor:
Junlong Zhao, Huichen Li, Shoujie Zhao, Enxin Wang, Jun Zhu, Dayun Feng, Yejing Zhu, Weijia Dou, Qingling Fan, Jie Hu, Lintao Jia, Lei Liu
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-16 (2021)
Abstract Background & Aims Hepatocellular carcinoma (HCC) is among the malignancies with the highest mortality. The key regulators and their interactive network in HCC pathogenesis remain unclear. Along with genetic mutations, aberrant epigenetic par
Externí odkaz:
https://doaj.org/article/d3e029ce3ea0472aa80f1d1d0a86c903
Autor:
Shuli Liang, Lijie He, Xiaodi Zhao, Yu Miao, Yong Gu, Changcun Guo, Zengfu Xue, Weijia Dou, Fengrong Hu, Kaichun Wu, Yongzhan Nie, Daiming Fan
Publikováno v:
PLoS ONE, Vol 6, Iss 4, p e18409 (2011)
BACKGROUND: MicroRNAs (miRNAs) are important regulators that play key roles in tumorigenesis and tumor progression. A previous report has shown that let-7 family members can act as tumor suppressors in many cancers. Through miRNA array, we found that
Externí odkaz:
https://doaj.org/article/6c3bd52d7c7049a5a4c24924bc87e2b0
Autor:
Shoujie, Zhao, Weijia, Dou, Qingling, Fan, Jie, Hu, Huichen, Li, Xiangnan, Zhang, Qian, Zhang, Lei, Liu
Publikováno v:
Ann Transl Med
Sorafenib has been recommended as the first-line treatment and shown to prolong median overall survival (OS) of patients with advanced unresectable hepatocellular carcinoma (HCC). Recently, a growing amount of research has supported the application o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::758c07f82810949c4dfde65d44baf240
https://pubmed.ncbi.nlm.nih.gov/33145261
https://pubmed.ncbi.nlm.nih.gov/33145261
Autor:
Huichen Li, Qingling Fan, Xiangnan Zhang, Weijia Dou, Shoujie Zhao, Xilin Du, Mengmeng Wang, Kai Tan, Lei Liu
Publikováno v:
Ann Transl Med
BACKGROUND: Recommended as the first-line treatment for advanced unresectable hepatocellular carcinoma (HCC), sorafenib has been shown to prolong median overall survival (OS) for patients. However, advanced HCC sees high heterogeneity across patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::016c6715764735e398a953f1df9574ee
https://pubmed.ncbi.nlm.nih.gov/33209862
https://pubmed.ncbi.nlm.nih.gov/33209862
Publikováno v:
Ann Transl Med
Background Alpha-fetoprotein (AFP) has been extensively applied in clinical practice to detect and predict postoperative outcomes of patients with hepatocellular carcinoma (HCC). However, due to its low sensitivity and specificity, its efficacy has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::815954e3e87012791127f0677e95a38e
https://pubmed.ncbi.nlm.nih.gov/33209863
https://pubmed.ncbi.nlm.nih.gov/33209863
Autor:
Enxin Wang, Weijia Dou, Chengguo Wang, Mengmeng Wang, Shoujie Zhao, Ting Zhang, Xilin Du, Lei Liu
Publikováno v:
Ann Transl Med
Background Hepatocellular carcinoma (HCC) is a common cancer worldwide and prognosis for patients with the disease remains poor. Most patients are diagnosed at an advanced stage and are only eligible for palliative therapy. As a novel vascular endoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75b21d3552dbe18588da74cf9e5348b
https://europepmc.org/articles/PMC7214911/
https://europepmc.org/articles/PMC7214911/
Autor:
ZHENXIONG LIU1, WEIJIA DOU1, ZHEN NI2, QINSHENG WEN1, RONG ZHANG3, MING QIN1, XUXIA WANG1, HUA TANG1, YING CAO1, JINGJIE WANG1 jingjie@fmmu.edu.cn, SHUGUANG ZHAO1 zsg1203@126.com
Publikováno v:
Molecular Medicine Reports. 2016, Vol. 14 Issue 2, p1323-1331. 9p.
Autor:
ZHENXIONG LIU1, WEIJIA DOU1, YUANYUAN ZHENG2, QINSHENG WEN1, MING QIN1, XUXIA WANG1, HUA TANG1, RONG ZHANG1, DANDAN LV1, JINGJIE WANG1 jingjie@fmmu.edu.cn, SHUGUANG ZHAO1 zsg1203@126.com
Publikováno v:
Molecular Medicine Reports. 2016, Vol. 13 Issue 2, p1717-1724. 8p.
Autor:
Lei Liu, Xiangnan Zhang, Qingling Fan, Dayun Feng, Jie Hu, Weijia Dou, Mengmeng Wang, Ting Zhang
Publikováno v:
Ann Transl Med
BACKGROUND: Liver resection has been widely applied as a curative measure in the treatment of hepatocellular carcinoma (HCC) patients. However, the high rate of postoperative recurrence observed following liver resection proposes a problem, the solut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9010fd9d3089be1f1b8aa310d5709b
https://doi.org/10.21037/atm.2020.02.111
https://doi.org/10.21037/atm.2020.02.111